Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A(2025) Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer Eur J Nucl Med Mol Imaging(in press) DOI 10.1007/s00259-025-07330-y, PubMed 40397137
Song L, Kostas M, Laerdahl JK, Skálová M, Janská T, Juzeniene A, Ræstad S, Krivokapic A, Kalantzopoulos GN, Soltes J, Vlk M, Kozempel J, Hassfjell S, Wesche J(2025) Preparation and Characterization of an Engineered FGF1 Conjugated to 161Tb for Targeting of FGFRs ACS Omega, 10(6), 5730-5743 DOI 10.1021/acsomega.4c09179, PubMed 39989790
Lindland K, Malenge MM, Li RG, Wouters R, Bønsdorff TB, Juzeniene A, Dragovic SM(2024) Antigen targeting and anti-tumor activity of a novel anti-CD146 212Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma Sci Rep, 14(1), 25941 DOI 10.1038/s41598-024-76778-z, PubMed 39472474
